observed a trend towards lower plasma levels of neuropeptide Y (NPY) – a peptide co-stored and co-released with NE, serving as an indirect biomarker [ 70 ] - compared with healthy controls, although this difference did not reach statistical significance [ 32 ].
← all excerpts
Noradrenergic system involvement as a major driver of tension-type headache: a systematic review of the current evidence.
1
—
—